Please login to the form below

Not currently logged in
Email:
Password:

Sue Mahony to retire as president of Lilly Oncology

She will continue in her position until August 31

Eli LillyEli Lilly’s senior vice president and president of Lilly Oncology, Sue Mahony, is set to retire at the end of August after 18 years of service with the company.

Mahony led Lilly Oncology through the integration of ImClone and launched several brands including Verzenio.

She also most recently led the refocusing of the company’s oncology R&D strategy.

Prior to this, as senior vice president of human resources and diversity, Mahony played in a role in restructuring the company into business units.

She said: “What I’ve appreciated over the years is the opportunity to participate in something greater than myself.

“We make medicines that help patients with cancer live longer and what a privilege it’s been to wake up each morning with that as my life’s work.”

Prior to her time with Eli Lilly, Mahony has served in various roles for Amgen, Bristol-Myers Squibb and Schering-Plough.

Lilly has said it is considering internal and external candidates to find Mahony’s successor.

5th June 2018

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

Sharing patient stories for World Pulmonary Hypertension Day
For World Pulmonary Hypertension Day and we’re here to help raise awareness of pulmonary hypertension (PH) - a frequently under and misdiagnosed condition. Created in collaboration with the PH patient...
How nature can help you manage the pressures of agency life
Paul Hutchings, founder of fox&cat, outlines how nature can help you can boost staff wellbeing in your agency this Mental Health Awareness Week...
How can we strike the right balance between familiarity and innovation when it comes to data presentation?
Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...